Status:
UNKNOWN
Geriatric Population COVID-19 Observational Study (GEROCOVIDobs)
Lead Sponsor:
Raffaele Antonelli Incalzi
Collaborating Sponsors:
Italian Society of Gerontology and Geriatrics
BLUECOMPANION FRANCE
Conditions:
COVID-19
Eligibility:
All Genders
60+ years
Brief Summary
The GeroCovid e-Registry is a European de-identified clinical data electronic registry of geriatric patients at risk or suffering from COVID-19 (suspected and confirmed cases) observed since 1st March...
Detailed Description
Older adults (≥ 65 years) and pre-geriatric population (≥60 years and \<65 years) are the ones most at risk from complications of COVID-19, including increased mortality, possibly in relationship with...
Eligibility Criteria
Inclusion
- Applying only to the " Acute Ward Patients " cohort:
- Hospitalised patients
- Suspected or known SARS-CoV-2 infection
- Applying only to the "Nursing Homes (RSA)" cohort:
- Nursing Home Resident Older Adults
- Suspected or known SARS-CoV-2 infection
- Applying only to the" Home and outpatients' care " cohort:
- a. Outpatients at risk of SARS-CoV-2 infection
- Applying only to the" Dementia outpatients " cohort:
- Outpatients suffering from dementia according to NIA-AA criteria
- At risk of SARS-CoV-2 infection
- Ongoing treatment with anti-cholinesterase- dugs and/or anti-psychotics
- Applying only to the" At home " cohort:
- a. Outpatients at risk of SARS-CoV-2 infection
- Applying only to the " Outcomes " cohort:
- Age≥65 years
- Hospitalised patients diagnosed with SARS-CoV-2 infection
Exclusion
- Lack of a signed Informed Consent if the patient received and understood the information about the study.
- Lack of a signed declaration by the responsible physician stating that no explicit opt-out advanced directives by the subject were known to be in place at the moment of inclusion if it had been impossible to inform the patient due to her/his state of consciousness and/or awareness of disease condition.
Key Trial Info
Start Date :
April 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2020
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04379440
Start Date
April 25 2020
End Date
November 30 2020
Last Update
May 7 2020
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
RSA La Quiete
Castiglione Cosentino, Calabria, Italy, 87040
2
ASP Catanzaro
Catanzaro Lido, Calabria, Italy, 88100
3
AOU Ferrara
Ferrara, Emilia-Romagna, Italy, 44124
4
Policlinico Campus Bio-Medico
Rome, Roma, Italy, 00128